Prevention continuum: an assessment of cardiovascular disease prevention based on the data from a survey of doctors

Aim. To assess the awareness and engagement of health professionals in Russia in the main aspects of cardiovascular disease prevention.

Material and methods. In order to assess engagement and awareness, an online survey of Russian primary health care providers was conducted in March 2021. The survey was conducted using original questionnaire, which includes the main questions aimed at early identification of patients with modifiable cardiovascular risk factors.

Results. In case of newly diagnosed hypercholesterolemia and elevated blood pressure during screening, 91,8% (n=458) of the surveyed medical specialists record the results and immediately consult the patient on these issues. Similar responses was obtained by 93% (n=464) of doctors for patients with previously prescribed antihypertensive and/or lipid-lowering therapy. In addition, 46,5% (n=232) responded that during screening, 10-30% of patients had newly diagnosed hypertension and/or total cholesterol >5 mmol/L. A total of 28,9% (n=144) of respondents noted that 30-50% of patients with newly diagnosed hypertension and/or total cholesterol >5 mmol/L are detected at screening. It is noteworthy that 41,9% (n=209) of physicians devote 1 to 5 minutes to a patient, describing the changes in lifestyle, diet and physical activity. For 35,1% (n=175) of the respondents, this takes from 5 to 10 minutes, 22% (n=110) — >10 minutes, while ~5 respondents refer patients to another specialist for this purpose.

Conclusion. The survey showed a high awareness of medical specialists in the need to monitor and modify risk factors. However, ~40% of surveyed doctors do not devote enough time to explaining issues of modifying lifestyle, diet and physical activity.

1. Morbidity of the population by the main classes of diseases. (In Russ.) https://rosstat.gov.ru/folder/13721. (27 october 2021).

2. COVID-19: a new lens for non-communicable diseases. The Lancet. 2020;396(10252):649. doi:10.1016/S0140-6736(20)31856-0.

3. Larson AS, Savastano L, Kadirvel R, et al. Coronavirus Disease 2019 and the Cerebrovascular-Cardiovascular Systems: What Do We Know So Far? J Am Heart Assoc. 2020;9:e016793. doi:10.1161/JAHA.120.016793.

4. Yahia F, Zakhama L, Abdelaziz AB. COVID-19 and Cardiovascular diseases. Scoping review study Tunis Med. 2020;98(4):283-94.

5. Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-covid syndrome in individuals admitted to hospital with Govid-19: retrospective cohort study. BMJ. 2021;372. doi:10.1136/bmj.n693.

6. Order of the Ministry of Health of the Russian Federation dated 31.072020 N 785n “On approval of Requirements for the organization and conduct of internal quality control and safety of medical activities” (Registered with the Ministry of Justice of the Russian Federation 02.10.2020 N 60192). (In Russ.) https://www.garant.ru/products/ipo/prime/doc/74610282/. (27 october 2021).

7. Murashko MA, Ivanov IV, Knyazyuk NF. Fundamentals of quality assurance and safety of medical activity: Monograph. M.: RIA “Standards and quality”. 2020. p. 408. (In Russ.) doi:10.35400/978-5-600-02711-4.

8. Drapkina OM, Drozdova LYu, Boytsov SA, et al. Temporary methodological recommendations: “Provision of outpatient medical care to patients with chronic diseases subject to dispensary supervision in the conditions of the COVID-19 pandemic”. Preventive medicine. 2020;23(3-2):4-41. (In Russ.) doi:10.17116/profmed2020230324.

9. Order of the Ministry of Health of the Russian Federation of 27.04.2021 N 404n “On approval of the Procedure for preventive medical examination and medical examination of certain groups of the adult population” (Registered with the Ministry of Justice of the Russian Federation 30.06.2021 N 64042). (In Russ.) http://www.consultant.ru/document/cons_doc_LAW_388771/. (27 october 2021).

10. Order of the Ministry of Health of the Russian Federation dated 29.03.2019 N 173n “On approval of the procedure for conducting dispensary supervision of adults” (Registered with the Ministry of Justice of the Russian Federation on 25.04.2019 N 54513). (In Russ.) https://www.garant.ru/products/ipo/prime/doc/72132764/. (27 october 2021).

11. Jousilahti P, Laatikainen T, Peltonen M, et al. Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study. BMJ. 2016;352:i721. doi:10.1136/bmj.i721.

12. Balanova YuA, Shalnova SA, Imaeva AE, et al. Prevalence of arterial hypertension, treatment and its effectiveness in Russian Federation (The data of observational study ESSE-RF 2) The Rational Pharmakotherapy in Cardiology. 2019;14(5):450-66. (In Russ.) doi:10.20996/1819-6446-2019-15-4-450-466.

13. Kobalava ZhD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.) doi:10.15829/1560-4071-2020-3-3786.

14. Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25( 11 ):4076. (In Russ.) doi:10.15829/29/1560-4071-2020-4076.

15. Martsevich SYu, Drozdova LYu, Voronina VP. Health and education of a physician: two parts of the success. Rational Pharmacotherapy in Cardiology. 2010;6(1):73-6. (In Russ.) doi:10.20996/1819-6446-2010-6-1-73-76.